<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.biomaterials.2022.121453</dc:identifier><dc:language>eng</dc:language><dc:creator>Prieto, Martin</dc:creator><dc:creator>Usón, Laura</dc:creator><dc:creator>García-Salinas, Sara</dc:creator><dc:creator>Yus, Cristina</dc:creator><dc:creator>Landa, Guillermo</dc:creator><dc:creator>Alejo, Teresa</dc:creator><dc:creator>Lujan, Lluis</dc:creator><dc:creator>Pérez, Marta</dc:creator><dc:creator>Irusta, Silvia</dc:creator><dc:creator>Sebastian, Victor</dc:creator><dc:creator>Mendoza, Gracia</dc:creator><dc:creator>Arruebo, Manuel</dc:creator><dc:title>Light activated pulsatile drug delivery for prolonged peripheral nerve block</dc:title><dc:identifier>ART-2022-128455</dc:identifier><dc:description>Regional anesthesia is widely used in peripheral nerve block and in neuraxial anesthesia to reduce anesthetics systemic side effects and shorten recovery times. However, when applied as a single injection (e.g., peripheral nerve block) it is limited by the duration of its effect. Herein, we develop a thermoresponsive nanogel based on poly(oligoethylene glycol methacrylate) containing the long-lasting anesthetic bupivacaine, which can be externally activated by using near-infrared light due to the photothermal properties of hollow gold nanoparticles embedded in the nanogel which facilitate its phase transition, triggering drug release at a controlled temperature above body temperature. Bupivacaine in vitro release can be repeatedly triggered to achieve a controlled pulsatile release of the drug due to the reversible nature of the thermosensitive nanogel, achieving a spatio-temporal control of the release. In vivo sciatic nerve block demonstrates that whereas the administered dose of free bupivacaine produces sensory block and impaired motor function for 2 h, the equivalent bupivacaine dose included in the developed release system can significantly prolong its neurobehavioral anesthetic effect for over 6 h. This release system can also be reactivated multiple times by subsequent irradiation cycles without observing detrimental toxicity in the infiltrated tissues. © 2022 Elsevier Ltd</dc:description><dc:date>2022</dc:date><dc:source>http://zaguan.unizar.es/record/163036</dc:source><dc:doi>10.1016/j.biomaterials.2022.121453</dc:doi><dc:identifier>http://zaguan.unizar.es/record/163036</dc:identifier><dc:identifier>oai:zaguan.unizar.es:163036</dc:identifier><dc:relation>info:eu-repo/grantAgreement/EUR/ERC-2013-CoG-614715</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/ISCIII/MS19-00092</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MCINN/PRE2018-085769</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MICINN BES-2015-073735</dc:relation><dc:identifier.citation>Biomaterials 283 (2022), 121453 [16 pp.]</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>